ZA202101894B
(en )
2022-08-31
Anti-pd-1 and anti-vegfa bifunctional antibody, pharmaceutical composition thereof and use thereof
IL279015A
(en )
2021-01-31
Anti-interleukin-17a antibody, pharmaceutical composition thereof and use thereof
HK1247214B
(en )
2019-07-19
Pdl-1 antibody, pharmaceutical composition thereof, and uses thereof
EP3505535A4
(en )
2020-04-15
Anti-pd1 monoclonal antibody, pharmaceutical composition thereof and use thereof
ZA201806576B
(en )
2020-01-29
Antibodies, pharmaceutical compositions and methods
SG11202105850YA
(en )
2021-07-29
Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof
SG11202003782XA
(en )
2020-05-28
Triple-chain antibody, method for preparation and use thereof
EP3597735A4
(en )
2020-11-25
Ctla4 antibody, pharmaceutical composition and use thereof
ZA202206885B
(en )
2023-04-26
Anti-pd-1-anti-vegfa bispecific antibody, pharmaceutical composition and use thereof
EP3491026A4
(en )
2020-07-29
Human antibodies, pharmaceutical compositions and methods
IL275798A
(en )
2020-08-31
Methods for antibody drug conjugation, purification, and formulation
EP3626266A4
(en )
2021-04-07
Pd-l1 antibody pharmaceutical composition and use thereof
IL290256A
(en )
2022-04-01
Anti-pd-1 antibody and pharmaceutical use thereof
IL273339A
(en )
2020-05-31
Griseofulvin compound and pharmaceutical use thereof
ZA202104518B
(en )
2023-01-25
Cd3 antibody and pharmaceutical use thereof
EP3714901A4
(en )
2022-03-02
Lag-3 antibody pharmaceutical composition and use thereof
EP4032904A4
(en )
2024-01-24
Anti-alpha-hemolysin antibody and use thereof
SG11202101435XA
(en )
2021-03-30
ANTIBODY AGAINST IL-1ß, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3856242A4
(en )
2022-05-18
Anti-siglec antibody, pharmaceutical composition comprising the same, and uses thereof
IL276323A
(en )
2020-09-30
4-methyldihydropyrimidinone compounds and pharmaceutical use thereof
IL274008A
(en )
2020-05-31
Anti-msln antibody and pharmaceutical composition comprising same for cancer treatment
SG11202011170YA
(en )
2020-12-30
Antibodies against lif and dosage forms thereof
EP3476864A4
(en )
2020-02-12
Etar antibody, pharmaceutical composition and use thereof
GB2590189B
(en )
2022-10-19
Lycorine derivative, and pharmaceutical composition and use thereof
EP3623384A4
(en )
2021-01-27
Anti-cldn-5 antibody, and drug containing said antibody